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Abstract
Background: Infantile colic is a distressing condition characterised by excessive crying in the first few months of
life. The aim of this research was to update the synthesis of evidence of complementary and alternative medicine
(CAM) research literature on infantile colic and establish what evidence is currently available.
Methods: Medline, Embase and AMED (via Ovid), Web of Science and Central via Cochrane library were searched
from their inception to September 2018. Google Scholar and OpenGrey were searched for grey literature and
PROSPERO for ongoing reviews. Published systematic reviews that included randomised controlled trials (RCTs) of
infants aged up to 1 year, diagnosed with infantile colic using standard diagnostic criteria, were eligible. Reviews of
RCTs that assessed the effectiveness of any individual CAM therapy were included. Three reviewers were involved in
data extraction and quality assessment using the AMSTAR-2 scale and risk of bias using the ROBIS tool.
Results: Sixteen systematic reviews were identified. Probiotics, fennel extract and spinal manipulation show promise to
alleviate symptoms of colic, although some concerns remain. Acupuncture and soy are currently not recommended.
The majority of the reviews were assessed as having high or unclear risk of bias and low confidence in the findings.
Conclusion: There is clearly a need for larger and more methodologically sound RCTs to be conducted on the
effectiveness of some CAM therapies for IC. Particular focus on probiotics in non-breastfed infants is pertinent.
Systematic review registration: PROSPERO: CRD42018092966.
Keywords: Colic, Systematic reviews, Overview, ROBIS, AMSTAR, Complementary and alternative medicine
Background
Description of the condition
Infantile colic (IC) is a common childhood condition af-
fecting 5% to 20% of infants worldwide [1, 2]. In 2016,
the new Rome IV criteria for colic defined it as ‘an infant
who is less than five months of age when symptoms start
and stop; recurrent and prolonged periods of infant cry-
ing, fussing or irritability reported by caregivers that
occur without any obvious cause and cannot be pre-
vented or resolved by caregivers; no evidence of infant
failure to thrive, fever or illness [3]’. Prior to this, colic
the was most commonly diagnosed using the Wessel
‘rule of three’ criteria [4].
Much research has been conducted over the past
50 years to try to establish the underlying aetiology. For-
mula intolerance, immaturity of gastrointestinal tract,
food allergies, intestinal cramping or excessive gas for-
mation have all been suggested [5], alongside psycho-
social causes, e.g. maternal anxiety and maternal-infant
bonding issues [6], but its pathophysiology remains un-
clear. Although it is considered a self-limiting condition,
it can be distressing for both parents and babies.
Conventional treatment options
Our lack of understanding of IC makes it difficult to find
an effective treatment. Current conventional treatments
include dietary (particularly mother’s diet), physical, be-
havioural and pharmacological. With little evidence to
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support the first three approaches, the medication
Simethicone is commonly used. However, this is no lon-
ger recommended on the NHS website [7].
CAM treatment options
Dissatisfaction with conventional health care and short-
age of treatment options may lead parents to seek com-
plementary and alternative (CAM) healthcare for their
infants. CAM has been defined as ‘… diagnosis, treat-
ment and/or prevention which complements main-
stream medicine by contributing to a common whole,
by satisfying a demand not met by orthodoxy or by
diversifying the conceptual framework of medicine’ [8].
New parents in particular find IC stressful, resulting in
high usage of CAM in this population [9]. Thus, further
investigation is needed to evaluate the effectiveness and
safety of CAM approaches and treatments. Information
and advice regarding the treatment or management of
colic is currently available to parents from a wide range
of generally unregulated sources (e.g. websites) often
which make claims that have no empirical support [10].
The main CAMs used for IC are probiotics, spinal ma-
nipulation, herbal medicine and acupuncture. A descrip-
tion of each alongside its justification for use in colic
can be found in Additional file 1.
Previous overview of reviews
There have been several previous overviews of reviews
investigating CAM interventions for IC which have pre-
dominantly focused on spinal/chiropractic manipulation
[11–13] or have included IC alongside other conditions
affecting children [14]. Most lack adequate quality as-
sessment of the included systematic reviews.
Why is it important to do this review?
Several trials have been published in recent years that
indicate an effect of some CAMs for IC; these have
mainly included trials of probiotics [6, 15–17]. The
aim of this overview is to synthesise CAM research
on IC and establish what evidence is currently avail-
able. As systematic reviews are considered the least
biased source of evidence to evaluate the effectiveness
of a particular intervention, this overview will focus
on reviews of IC.
Methods
This systematic overview was conducted following a pre-
determined written protocol registered on the PROS-
PERO database: registration number CRD42018092966.
To be considered eligible for this overview, reviews were
required to meet the following criteria:
Type of reviews—all systematic reviews of randomised
controlled trials (RCTS) of infantile colic (IC).
Type of participants—human subjects diagnosed with
infantile colic using standard diagnostic criteria (e.g.
WESSEL criteria3). No restrictions regarding gender,
condition duration or intensity were applied. Age was
restricted to infants under 1 year.
Type of intervention—reviews of effects of any CAM
therapies. Reviews that included multiple CAM therapies
were also included, as long as the CAM therapies were
not used in combination.
Type of comparator—placebo, active treatment, no
treatment, treatment-as-usual or waitlist control groups.
Type of outcome—any review that included studies
that reported measures of colic severity (e.g. parent-
reported crying diaries; questionnaires and parental
interviews).
The full criteria are listed in Table S4, Additional file 1.
Data sources
Medline, Embase and AMED (via Ovid), Web of Sci-
ence and Central via Cochrane library were searched
from their inception to September 2018. Google
Scholar (first 20 pages) and OpenGrey were searched
for grey literature and PROSPERO for ongoing reviews.
All reviews from 2011 were assessed for eligibility. The
search strategy was structured using subject (MeSH)
headings, text word terms and their derivatives: hom-
oeopath, acupuncture, spinal manipulation, hypnosis,
reflexology, phytotherapy, probiotics, infant, colic, sys-
tematic review, meta-analysis. Full details of the search
can be found in Additional file 1.
Data extraction
One reviewer (RP) extracted data and summarised the
review characteristics (see Table 1). Extracted data was
checked by another reviewer (VL or PD). Disagreements
were resolved through discussion. Information was ex-
tracted on author, date of review, country, list of studies
included in the individual review, intervention and com-
parator summary, number of participants, diagnosis cri-
teria, meta-analysis results or summary of main
between-group results, whether a sensitivity or subgroup
analysis was conducted, risk of bias assessment and ad-
verse events.
We reported the standard mean difference (SMD) and
95% confidence intervals (CI) and results of any tests of
heterogeneity reported in the relevant meta-analyses. In-
dividual study results (mean and standard deviation
(SD)) of continuous variables and any between-group
statistical analysis were reported when there were no
pooled results available (Additional file 1: Table S7).
Pooled odds ratios or risk ratios and associated 95% CIs
were reported for any dichotomous data.
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Data synthesis
Due to the expected overlap of studies and heterogeneity
between reviews (particularly with regard to intervention
and comparator arms), we conducted a narrative synthe-
sis of the findings rather than pooling of meta-analyses
from the included reviews. We applied the following
thresholds for the interpretation of the reported I2 statis-
tic that assesses heterogeneity [18] in any reported
meta-analysis.
 0% to 40%: might not be important
 30% to 60%: may represent moderate heterogeneity
 50% to 90%: may represent substantial heterogeneity
 75% to 100%: considerable heterogeneity
Assessment of methodological quality/bias of the
included reviews
The quality of each systematic review was assessed using
the newly developed AMSTAR-2 scale (Assessing the
methodological quality of systematic reviews [19]). This
is the revision to the validated and frequently used
AMSTAR scale [20]. This was used alongside the ROBIS
tool (Risk of Bias in Systematic Reviews tool [21]).
Three reviewers (RP, VL, PD) independently assessed
each review using both tools. Two reviewers had limited
experience of using the ROBIS tool, so a third reviewer,
who helped develop the tool (PD), was asked to
complete both ratings. Meta-analyses were checked by a
statistician experienced in meta-analyses (CP).
Deviation from the protocol
There were two changes to the protocol; originally, we
were going to exclude reviews that reported on multiple
conditions of which infantile colic was one, but we chan-
ged this to include reviews that had at least two studies
of IC described, to capture more data. We also allowed
active treatments to be the comparator option.
Results
Results of the literature search
The search identified 903 potentially relevant papers and
669 titles/abstracts were screened (see Fig. 1). Forty-three
full text articles were assessed for eligibility and 16 system-
atic reviews were included in this overview. Results of the
included reviews are presented in Table 1 (details of the
individual studies can be found in Additional file 1: Table
S7). Only identifiable randomised controlled trials (RCTs)
from each review are reported. The summarised
AMSTAR-2 scores and ROBIS scores are presented in Ta-
bles 2 and 3. Further justification statements for ROBIS
are presented in Additional file 1: Table S6. All excluded
reviews are listed in Additional file 1: Table S5.
The 16 included reviews [22–37] were published be-
tween 2011 and 2018. The reviews were conducted
from the following countries: three were from the UK
and Australia, two from Poland and one each from
France, Mexico, Canada, Norway, Germany, Saudi
Arabia, China and the USA. The reviews investigated
the following therapies: herbal medicine (n = 1), acu-
puncture (n = 1), manipulation (n = 3), multiple CAMs
(n = 4) and probiotics (n = 7). The majority assessed
crying time or reduction in symptoms of colic as the
main outcome. There was considerable overlap be-
tween studies reported in the included reviews (see
Additional file 1: Table S7, for clarity).
Results from each CAM therapy
Manipulation reviews
Spinal manipulation was assessed in six reviews [22, 23,
25–28]. Two multiple CAM reviews assessed manipula-
tion but did not pool the results [22, 25]. Both found three
trials to be effective [68, 69, 72, 73, or] with the exception
of one [71].
Dobson et al.’s [26] Cochrane review of spinal manipu-
lation therapy (SMT) found that five of the six included
studies reported a beneficial effect on the course of colic.
They found manipulation therapies had a greater effect
on daily crying time, reducing it by 1 h 12 min/day on
average with moderate heterogeneity (MD = − 1.20; 95%
CI − 1.89 to − 0.51, I2 = 56%). However, there was no evi-
dence of a difference when restricting to the studies
judged as having a low risk of performance bias (blind-
ing of parent outcome assessors). Three studies mea-
sured full recovery (odds ratio [OR] = 11.12; 95%CI 0.46
to 267.52, I2 = 89%), but confidence intervals were
extremely wide and heterogeneity was substantial.
Adverse events were only assessed in one study [83] and
none were found. Overall, firm conclusions cannot be
drawn from such limited data. The GRADE (Grading of
Recommendations Assessment, Development and
Evaluation) evaluation indicates low quality of evidence
for both outcomes. The results from AMSTAR-2 and
ROBIS indicate a high level of confidence in the
findings and were judged to be of low risk of bias in all
domains.
Gleberzon et al.’s [27] narrative synthesis included three
RCTs of SMT for infantile colic [68, 71, 84]. Two of these
RCTs were reported in Dobson et al.’s [26] review. Brown-
ing et al.’s [84] trial was excluded from the Dobson review
as it compared two active treatments (spinal manipulation
and occipito-sacral decompression). Just one trial indi-
cated an effect on IC symptoms compared to comparator
[68]. There were issues with both quality (AMSTAR-2)
and bias (ROBIS) with this review.
Carnes et al. [28], in their update of the Cochrane re-
view by Dobson et al., [26] identified five RCTs of IC.
Browning et al.’s [84] trial was included despite compari-
sons with an active treatment. They conducted a pooled
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analysis of four colic studies that were also included in
Dobson et al.’s meta-analysis [68, 71, 72, 83] (although
Carnes et al. used a different version of Miller et al.’s
trial [80]). They reported a similar reduction in crying
time ((MD = − 1.27 h, 95% CI − 2.29 to − 0.36, P = 0.006,
I2 = 69%), again, heterogeneity was substantial and issues
with quality and bias were evident.
Gutierrez-Castrellon et al.’s [25] network meta-
analysis (NMA) supported the effectiveness of manipu-
lation studies for IC, pooling the results of five RCTs
[68, 71, 72, 80, 81] and found a weighted mean differ-
ence [WMD] of − 37.4 min (95% CI, − 21.5 to − 67.0),
P = 0.001, I2 = 78%) compared to control. The overall
confidence in results was critically low (AMSTAR-2)
and risk of bias high (ROBIS).
Herbal medicine
There was one main review of herbal medicine [30]. It
assessed various types of herbal medicine for several
conditions. We extracted just the data on infantile colic.
Evidence was found for different fennel preparations
(e.g. oil, tea, herbal compound Colimil) in treating chil-
dren with colic, whereas peppermint oil was not found
to be effective. No serious adverse effects were reported.
Herbal medicine was also assessed in the four multiple
CAM reviews [22]. The same studies were included.
Gutierrez-Castrellon et al. [25] pooled various herbal ex-
tract studies (peppermint, fennel seed oil, Colimil (con-
taining Matricariae recutita, Foeniculum vulgare and
Melissa officinalis) in their NMA and demonstrated a
weak effect, (WMD= − 61.2 min (95% CI 0.8 to − 122.0,
P = 0.05, I2 is 98%). The wide confidence intervals, consid-
erable heterogeneity and the crossing of the line of
no effect suggest that herbal medicine has limited
effect on crying time. In conclusion, Gutierrez-
Castrellon et al. does not recommend herbal medi-
cine for colic.
Harb et al. [24] conducted a subgroup meta-analysis
focussing only on extracts containing fennel and demon-
strated it to be effective for reducing colic symptoms in
solely breast-fed infants. However, this analysis also had
considerable heterogeneity and wide confidence intervals
(MD = − 72.07, 95% CI − 126.43 to − 17.70, I2 = 99.5%).
It should be noted that much of the fennel oil evidence
stems from one trial (Arikan et al. 2008 [73]) which was
at particular risk for blinding, selective reporting and is-
sues of randomisation. Massage was one of the arms in
this trial; a therapy where it is impossible to blind the
therapist. Further, the wide confidence intervals and the
crossing of the line of no effect suggest that this trial has
limited, if any, value. These issues certainly cast concern
on the overall findings.
Perry et al. [22] and Bruyas-Bertholon et al. [23] both
reported results that demonstrated fennel herbal extracts
to be effective in reducing colic symptoms, but both
concluded that the methodological issues of the individ-
ual studies (discussed above) call these results into
question.
Fig. 1 Flow diagram
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Acupuncture
One systematic review of acupuncture [29] used individual
participant raw data (IPD) which is considered the gold
standard of evidence synthesis due to the high level of
precision and consistency [38]. A difference was found at
the mid time-point analysis favouring acupuncture: MD=
− 24.9 min (95% CI − 46.2 to − 3.6; P = 0.02, I2 = 9%), but
not after the removal of the one unblinded trial, [47]
(MD= − 13.8, 95% CI − 37.5 to 9.9, P = 0.25, I2 = 0%). The
GRADE evaluation indicates moderate quality evidence.
No major adverse events occurred although acupuncture
induced some crying during treatment, believed to be
linked to the insertion of needles into the infant [39, 40].
This was a well-conducted review that was judged to be
low risk of bias in most domains, but with low confidence
in the results (AMSTAR-2). One issue with this review is
the authors assessed all their own trials [46, 78, 84], al-
though they appeared to be objective in their evaluation.
Gutierrez-Castrellon et al. [25] pooled two of the above
studies [53, 57] and initially found an effect favouring acu-
puncture (at week 1 and 2) but was no longer evident by
week 3 (WMD of − 11.2 min (95% CI 2.0 to − 23.0), P =
0.08, I2 = 0%). There were issues with bias and quality in
the review process. Bruyas-Bertholon et al. [23] echoed
these findings in their multiple CAM review.
Probiotics
We identified seven reviews focussing on probiotics [31–
37]. The most commonly reported probiotic was Lactoba-
cillus reuteri DSM17398. The majority of reviews were
rated as having high or unclear risk of bias (ROBIS) and
confidence in the results were considered to be critically
low (AMSTAR-2).
Sung et al. [31] examined the effectiveness of L. reuteri
DSM17938 versus either placebo or the drug simethi-
cone. They meta-analysed three trials of breast-fed in-
fants [15, 62, 74] and found a mean reduction in daily
crying time of 67 min compared to control (N = 209;
MD = − 67.72 [95% CI − 99.79 to − 35.64]) at day 21 with
substantial heterogeneity (I2 = 70%). Anabrees et al. [32]
pooled the same three trials but found a mean reduction
in crying time of 56 min (N = 209:MD = − 56.03; [95% CI
− 59.92 to − 52.15], P < 0.00001, I2 = 0%) favouring pro-
biotics, which is a different pooled estimate and I2 result.
Table 3 Tabular presentation for ROBIS results
Review Phase 2 Phase 3
1. Study
eligibility
criteria
2. Identification
and selection
of studies
3. Data collection
and study
appraisal
4. Synthesis
and findings
5. Risk of
bias in
the review
Multiple CAM therapies
1. Perry [22] Low Unclear Low Low Low
2. Bruyas-Bertholon [23] High High Unclear High High
3. Harb [24] High High Low High High
4. Gutierrez-Castrellon [25] Unclear High High High High
Manipulation therapies
5. Dobson [26] Low Low Low Low Low
6. Gleberzon [27] High High Unclear Unclear High
7. Carnes [28] Low Low Low High Unclear
Acupuncture
8. Skejeie [29] Low Low Low Low Unclear
Herbal medicine
9. Anheyer [30] Unclear High Low High High
Probiotics
10. Sung [31] Unclear Low Low High Unclear
11. Anabrees [32] Low Low Low High Low
12. Urbanska [33] Low High High High High
13. Xu [34] Unclear Low Low Unclear Low
14. Shreck Bird [35] High High Low High High
15. Dryl [36] High High Unclear High High
16. Sung [37] High Unclear Unclear Unclear Unclear
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This appears to be due to differences in how the authors
estimated means + SD from medians. Subgroup analysis
of probiotics versus indistinguishable placebo showed a
similar reduction in crying time at 21 days (MD = −
55.48 [95% CI − 59.46 to − 51.49], I2 = 0%). In a separate
analysis, probiotics were also shown to improve treat-
ment success at 21 days (RR = 0.06 (95% CI 0.01 to
0.25), P < 0.000001, I2 = 0%).
Urbanska et al. [33] and Xu et al. [34] restricted their
analysis to trials of L. reuteri versus indistinguishable pla-
cebo only. Urbanska et al. [33] pooled three trials and
found that L. reuteri DSM17938 reduced crying time by
43 min on day 21, (N = 244:MD= − 43.32 [95% CI − 67.62,
− 19.02], P = 00005). Heterogeneity was substantial (I2 =
79%). A subgroup analysis of two studies of just breastfed
infants was conducted and a greater reduction in crying
time of 56 min (I2 = 0%) was found. Xu et al. [34] meta-
analysed five trials and demonstrated that L. reuteri
decreased crying time at 21 days by 45 min (WMD= −
45.83; [95% CI − 59.45 to − 32.2], P = 0.0001). Heterogen-
eity was moderate (I2 = 57%). At 4 weeks, pooling three
trials demonstrated a similar effect (WMD= − 56.32 min
(95% CI − 89.49 to − 23.16, P = 0.001; I2 = 87.7%). They
also found that L. reuteri improved colic treatment effect-
iveness at three but not 4 weeks.
Schreck Bird et al. [35] pooled five trials of L. reuteri
(ATCC55730 or DSM17938) versus either placebo or
simethicone and found that there were more responders
(infants with ≥ 50% reduction in crying/fussing time
from baseline) in the probiotic group than the control
(2–3-fold greater chance of responding: RR = 2.34, P =
0.01). A fixed-effects model demonstrated substantial
heterogeneity (I2 = 86.1%). Dryl et al. [36] assessed both
probiotics (L. reuteri DSM17938, Lactobacillus rhamno-
sus GG4.5) and synbiotics and also found a reduction in
the average crying /fussing time. Again, responders were
defined as above (RR = 1.67[95% CI 1.10 to 2.51]).
The most up-to-date review was by Sung et al. [37] who
compared L. reuteri DSM17398 versus placebo using indi-
vidual participant raw data (IPD). Assessments took place
at day 7, 14 and 21. The probiotic group averaged less cry-
ing and/or fussing time than placebo group at all time
points. The results at day 21 using IPD were − 25.4 min
(95% CI − 47.3 to − 3.5) P < 0.05 (adjusted for baseline).
Intervention effects were particularly impressive in breast-
fed infants—MD= 46.4 min (95% CI − 67.2 to − 25.5, P <
0.05), but not so in formula-fed infants—MD= 41.0 (95%
CI − 20.1 to 102.2, P > 0.05).
Probiotics were also discussed as part of four multiple
CAM reviews [22–25]. Both the NMA [25] and Harb
et al.’s [24] meta-analysis supports the above findings that
L. reuteri reduces crying time compared to placebo or
simethicone (WMD= − 51.3 min (95% CI − 30.5 to − 72.2),
P = 0.0001, I2 = 42%; MD= − 55.84, 95% CI − 64.41 to −
47.26), I2 = 77.1%, displayed respectively). Bruyas-Bertholon
et al. [23] also found probiotics to be effective, whereas
Perry et al. [22] did not; however, this latter review was
conducted prior to the recent supportive evidence.
Other CAM therapies
Several other CAMs were assessed as part of the mul-
tiple CAM reviews [22–25]. Three trials favoured sugar
solutions over either placebo control [59, 61], or no
treatment [73]. Three trials [66, 73, 82] assessed mas-
sage, of which a pooled estimate of two trials [66, 82]
demonstrated an effect. One trial on reflexology [67]
found no difference compared to the control. Two trials
assessed soy added to formula [60, 78], but it was not
possible to report the pre-washout data [60] or distin-
guish the soy data from other supplements analysed.
Adverse events
With regards to the safety of the reported CAMs, there
have been some concerns raised in recent years. In par-
ticular, manipulation therapies have come under scrutiny
[41, 42] but serious adverse events are rare [43]. Reported
adverse events from probiotics are generally mild gastro-
intestinal disorders such as abdominal cramping, nausea,
diarrhoea, flatulence and taste alteration [44].
Poor reporting of adverse events (AEs) is a common
criticism of CAM research [45]. It is particularly difficult
in infants who cannot communicate their responses ef-
fectively. AEs in our included reviews were primarily
based on parental reports. However, nine of the 16 re-
views did report on AEs with the majority reporting that
there were none. The acupuncture review [29] had the
highest number of AEs from acupuncture (i.e. bleeding
at acupoint, increased hiccoughing), although these are
relatively minor. Just six reviews did not report or only
partially report on AEs [23, 25, 27, 31, 32, 36]. In
addition, several trials ignored safety issues by not pro-
viding the reasons why subjects dropped out. Also, due
to the small sample sizes of the trials, it is difficult to
draw definitive conclusions on safety.
Quality of the included reviews
Results of AMSTAR-2
A summary of the AMSTAR-2 results can be found in
Table 2. Most reviews were rated as having critically
low confidence in the results, four were rated a low and
one (the Cochrane review [26]) was considered to have
high confidence in the results. Seven questions that re-
late to critical domains were identified by Shea et al.
[19]; more information about these domains can be
found in Additional file 1.
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Results of ROBIS
The ROBIS tool is divided into four domains (see Table 3
for summary of results and Additional file 1: Table S6
for full results). With regard to domain 1, which assessed
any concerns regarding specification of study eligibility
criteria, six reviews achieved a low risk of bias rating
overall [22, 26, 28, 29, 32, 33]. Domain 2 assessed any
concerns regarding methods used to identify/select
studies and six achieved a low risk of bias rating overall
[26, 28, 29, 31, 32, 34], two were rated as unclear [22, 37]
and the remaining eight achieved a high risk of bias rating.
Domain 3 assessed concerns regarding methods used
to collect data and appraise studies. Ten of the 16
reviews achieved a low risk of bias rating overall. With
regards to domain 4, which assessed concerns regarding
the synthesis and findings, the majority were rated as
high risk of bias. The final section of the tool pro-
vides a rating for the overall risk of bias of all the re-
views; four achieved a low rating [22, 26, 32, 34], four
[28, 29, 31, 37] an unclear rating and eight a high
rating [23–25, 27, 30, 33, 35, 36].
Discussion
Summary of the main results
Manipulation
From the six reviews that reported on spinal manipula-
tion, the most robust evidence comes from Dobson
et al.’s [26] Cochrane review, rated as good quality
(AMSTAR-2) with low risk of bias (ROBIS). The other
reviews had issues with bias (apart from two [22, 28])
and quality. Most trials indicate a positive effect on cry-
ing time alongside other improvements (e.g. ‘recovery
from colic’). Blinding was an issue in most trials as the
clinician will always know whether they performed a
treatment. Thus, the effectivenss of the intervention was
called into question when the analyses were restricted to
trials with adequate blinding.
Herbal medicine
From the five reviews that reported on herbal medicine,
preparations containing peppermint demonstrated no
evidence of effect. Preparations containing fennel oil
demonstrated some effect for reducing the symptoms of
colic, but there were limitations to these findings with
regards to quality and bias in the review process. Well-
designed clinical trials are required to strengthen the
evidence.
Acupuncture
One systematic review of acupuncture [29] found some
evidence of effect of acupuncture but this disappeared
when the unblinded trial was removed. They conclude
that needle acupuncture should not be recommended
for infantile colic on a regular basis. This review scored
‘low’ in most domains of ROBIS, but low overall confi-
dence in result (AMSTAR-2). Gutierrez-Castrellon et al.
[25] supported these findings and Bruyas-Bertholon
et al. [23] found an initial effect that disappeared at week
3. It is important to note that using acupuncture in in-
fants may raise ethical issues for future trials, as the in-
fant’s response to needle insertion is difficult to evaluate
[46] and parents may feel anxious about needles being
inserted into their child [40].
Probiotics
The majority of probiotic reviews indicated that L. reu-
teri is effective in reducing symptoms of colic. Some re-
views were of better quality than others as assessed by
AMSTAR-2 [32] and ROBIS [32, 34]. There were issues
of quality with most of these reviews, so caution is
needed before firm conclusions can be drawn. The fol-
lowing issues were identified:
 Simithicone was used as a placebo in one trial [62]
which was then included in three meta-analyses [31,
32, 37]. As it is an active treatment, the robustness
of the results of these meta-analyses needs to be
taken with caution.
 Several reviews [33, 34, 36, 37] reported a difference
in the efficacy of L. reuteri between breastfed and
formula-fed infants; however, on closer inspection,
there was just one study of formula-fed infants
which included some mixed-fed babies. Thus, their
conclusions over-emphasise the impact of their
results.
 Reviewers [35–37] combined different outcomes
from the Sung et al. [6] trial. Either ‘crying’ and
‘crying/fussing’ times were analysed, it was unclear
why reviewers either combined or separated these
outcomes.
 The use of medians in some reported meta-analyses
was also problematic and it was unclear if the
conversion to means had actually taken place. It was
also unclear why different pooled estimates were
found when using the same studies [31, 32].
Overall, these reviews suggest that probiotic L. reuteri
may lead to reduced crying time in IC; however,
cautious interpretation must be taken due to substantial
heterogeneity and small number of trials in the analyses,
and low-quality evidence of most of the reviews.
Other CAMs
There was some support for both sugar solutions [59,
61, 73] and massage [66, 82], but the trials of reflexology
[67] and soy formula [60, 78] did not show support.
Concerns regarding the high phytoestrogen content of
soy [46, 47] reiterated in a recent Cochrane review of
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dietary interventions for IC (October 2018) [48] makes
this difficult to recommended.
Future work
It is important to highlight that the nonspecific effects
(e.g. the therapeutic effects of time, attention and touch
alongside the placebo effect) of many CAM therapies
included in this review are poorly understood but may
play a role.
The self-limiting nature of infantile colic means that
RCTs are the best way to assess the effectiveness of
treatments. Given that there was little convincing
evidence for acupuncture, and because funding for CAM
research is difficult to obtain, additional research should
focus on treatments that offer the most robust evidence.
Thus, as encouraging results were demonstrated for
manipulation, fennel extracts and sugar solutions, these
CAMs require further investigation through well-
designed RCTs.
Recent research into colic has focused on probiotics.
The majority of reviews concluded that further trials
into probiotics for breastfed-only infants are no longer
needed. On closer inspection, this conclusion might be
premature as the quality of the evidence is currently low.
Its role in formula-fed babies certainly requires further
research but trialling this will be more problematic as in-
fant formulas commonly contain probiotics [49]. Crying
time as measured by parental diaries was the main out-
come in most reviews, which is highly subjective; more
consideration is needed to accurately measure crying
time in future trials (e.g. phone audio or video record-
ings of the colic episodes).
CAM therapies are difficult to study as some of the
most common treatments, (e.g. acupuncture, osteopathy
and chiropractic) cannot be adequately blinded. Even tri-
als of other CAMs (such as herbal remedies) have had
difficulty in blinding, making it impossible to totally
remove bias from the research studies. However, it ap-
pears that parents are driving the use of CAM therapies
due to limited routine medical care solutions for prob-
lem of infant colic. Therefore, those therapies with
promising emerging evidence that have, so far, been
found safe or without adverse events such as herbal
medicines (in particular, fennel oil), probiotics, chiro-
practic and osteopathic manual therapies may provide
reasonable approaches to the problem. Nevertheless, the
evidence is far from definitive and more high-quality re-
search is required to help parents decide on the most ef-
ficacious therapy for their infant suffering from colic.
Potential bias in the overview process
One reviewer (RP) assessed their own work in this over-
view [22]; however, two other reviewers also assessed
each review using AMSTAR-2 and ROBIS. One of the
developers of the ROBIS tool was involved (PD). She
was invited for her level of expertise in using the ROBIS
tool, as the other reviewers had limited experience.
Strengths and limitations
The search was thorough and included grey literature
searching. We believe the systematic approach taken in
this overview limits bias. Difficulties in using both
ROBIS and some questions on AMSTAR-2 may have
led to errors in assessment.
Conclusions
Spinal manipulation shows promise to alleviate symp-
toms of colic, although concerns remain as positive ef-
fects were only demonstrated when crying was measured
by unblinded parent assessors. Fennel is the most prom-
ising herbal remedy, but again concerns on the quality
of the included studies make any conclusions cautionary.
The majority of the reviews indicate that L. reuteri
DSM17938 should be recommended for breastfed in-
fants with colic, but caution is needed due to the poor
quality of the included reviews. Its role in formula-fed
babies, in particular, needs further research. Acupunc-
ture and soy are currently not recommended. More
rigorous clinical trials are needed for these interventions.
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